2-Chlorophenylboronic acid → HCID 68663729, compound
Reaction equation
Br[C:2]1[C:10]2[C:5](=[CH:6][N:7]=[C:8]([C:11]3[O:12][C:13]([CH3:16])=[N:14][N:15]=3)[CH:9]=2)[O:4][CH:3]=1.[Cl:17][C:18]1[CH:23]=[CH:22][CH:21]=[CH:20][C:19]=1B(O)O>>[Cl:17][C:18]1[CH:23]=[CH:22][CH:21]=[CH:20][C:19]=1[C:2]1[C:10]2[C:5](=[CH:6][N:7]=[C:8]([C:11]3[O:12][C:13]([CH3:16])=[N:14][N:15]=3)[CH:9]=2)[O:4][CH:3]=1Participants
3
Procedure
In the same manner as in Example 132 and using 3-bromo-5-(5-methyl-1,3,4-oxadiazol-2-yl)furo[2,3-c]pyridine instead of 2-(3-bromo-1-benzofuran-5-yl)-5-methyl-1,3,4-oxadiazole and using (2-chlorophenyl)boronic acid instead of (4-fluorophenyl)boronic acid, the title compound (yield 21%) was obtained as colorless crystals.
Sources & evidence
- ORD record
- ord-f05bfab976664d0fbe4fc2b63e2193e8
- Source dataset
- uspto-grants-2013_07
- Patent number
- US08492378B2
Reaction notes
Loading…